New research is constantly being done in the medical field, medication being among those. There has been a discussion of allowing psychedelic drugs to be returned to research labs and to yet again be used for research purposes. Since psychedelics are seen negative, a lot of the research dates far back, however since the conversation is coming back, there is new research that is coming into light. Psychedelic drugs are drugs that alter the state of perception, thought, and feeling and also heighten sensory which also leads to the feeling of little to no control of what is being experienced. The articles that bring attention to psychedelics can be divided into separate categories that allow for ‘groups’ to form on the similarities and differences
…show more content…
Many articles focus on depression and anxiety mainly because of the effect psychedelics have on the mind. The article Psilocybin with Psychological Support for Treatment-Resistant Depression: An Open-Label Feasibility Study written by Harris Carhart goes over a study done of 12 people who had major depression that resisted treatment. All 12 were given two doses of psilocybin, a psychedelic, and it was found that after a week some recipients had reduce symptoms of depression and anxiety, and after a three months all recipients reported reduced symptoms. Another article, Antidepressant Effects of a Single Dose of ayahuasca in Patients with Recurrent Depression: A Preliminary Report, written by Osório, Flávia talks about another study done with six individuals. These individuals had a current depressive episode and were given Ayahuasca, another type of psychedelic, and after 21 days decreases up 82% were showed in depressive scores. Both of these articles show that those who were treated with psychedelics in a research setting show significant improvements. The next article written by Charles S. Grob, Classic Psychedelics and Rational Suicide in the Elderly: Exploring the Potential Utility of a Re Emerging Treatment Paradigm, talks about how suicide within the elderly age group. It poses the idea that psychedelic drugs can reverse suicidal thoughts by reducing pain, depression and anxiety along with being in a controlled and monitored setting. These articles focus on the positive effects psychedelics have on individuals who experience depression and
Many articles focus on depression and anxiety mainly because of the effect psychedelics have on the mind. The article Psilocybin with Psychological Support for Treatment-Resistant Depression: An Open-Label Feasibility Study written by Harris Carhart goes over a study done of 12 people who had major depression that resisted treatment. All 12 were given two doses of psilocybin, a psychedelic, and it was found that after a week some recipients had reduce symptoms of depression and anxiety, and after a three months all recipients reported reduced symptoms. Another article, Antidepressant Effects of a Single Dose of ayahuasca in Patients with Recurrent Depression: A Preliminary Report, written by Osório, Flávia talks about another study done with six individuals. These individuals had a current depressive episode and were given Ayahuasca, another type of psychedelic, and after 21 days decreases up 82% were showed in depressive scores. Both of these articles show that those who were treated with psychedelics in a research setting show significant improvements. The next article written by Charles S. Grob, Classic Psychedelics and Rational Suicide in the Elderly: Exploring the Potential Utility of a Re Emerging Treatment Paradigm, talks about how suicide within the elderly age group. It poses the idea that psychedelic drugs can reverse suicidal thoughts by reducing pain, depression and anxiety along with being in a controlled and monitored setting. These articles focus on the positive effects psychedelics have on individuals who experience depression and